On
31 May, 2016, Chongqing Lummy Pharmaceutical Co., Ltd. (Chongqing Lummy), a
domestic listed pharmaceutical enterprise (stock code: 300006), announced that
it had applied for the withdrawal of glutamine capsule registration and got
approved by the China Food and Drug Administration (CFDA).
"We made this decision after deliberate consideration, taking into account
the company's reality and the latest policies released by the CFDA," said
Chongqing Lummy.
Early in Jan. 2009, the company had applied for the clinical trial on glutamine
capsule (0.25 g/capsule) and got accepted (Acceptance No.: CYHS0900040). This
capsule is an amino acid drug used for the treatment of gastric and duodenal
ulcers.
\
Glutamine, one of the most common amino acids in daily life, plays a vital role
in adjusting protein synthesis, restraining protein degradation, promoting cell
growth, activating immune system and increasing growth hormone. Thus, it is
widely applied in fields of food, pharmaceuticals, feed and so on. For
instance,
-
Japan: L-glutamine
was launched as an anti-ulcer drug in 1979
-
The US: L-glutamine
is largely used in healthcare products treating gastric ulcer and
nutrition supplements for athletes
-
German: L-glutamine
has been recorded onto pharmacopeia as a drug for gastritis, gastric and
duodenal ulcers
So far, several Chinese enterprises have been got approvals for production and
import of L- glutamine API, tablets and capsules. Leading glutamine preparation
producers include YaoPharma Co., Ltd., Jiangsu Shenhua Pharmaceutical Co., Ltd.
and Shandong Lukang Pharmaceutical Group Co., Ltd.
Chongqing
Lummy, founded in 1999, is a high-tech pharmaceutical enterprise devoted to the
R&D, production and sale of anti-infection and specialized drugs. It is one
of the domestic producers boasting the most complete injection formulations,
such as small & large volume injections, powder injections and freeze-dried
powder injections. Notably, in Q1 2016, the company reported a large YoY
increase of 239.66% in net profit.
*This article comes from Amino Acid China News 1606, CCM
About CCM:
CCM is the leading market intelligence
provider for China’s agriculture, chemicals, food & ingredients and life
science markets. Founded in 2001, CCM offers a range of data and content
solutions, from price and trade data to industry newsletters and customized
market research reports. Our clients include Monsanto, DuPont, Shell, Bayer,
and Syngenta. CCM is a brand of Kcomber Inc.
For more information about CCM, please
visit www.cnchemicals.com or get in touch with us directly by emailing econtact@cnchemicals.com or calling +86-20-37616606.
Tag: glutamine